Insider Stock Trading History of Kramer Michael R


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kramer Michael R since year 2005. The trader's CIK number is 1380079. At the time of this reporting, Kramer Michael R is the Chief Financial Officer of Trivascular Technologies, Inc. . (stock ticker symbol TRIV). See this page for all insider trading activities at Trivascular Technologies, Inc. .

Note that in the past Kramer Michael R also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kramer Michael R since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-02-03 TRIV Trivascular Technologies, Inc. Option Ex 31,032 1.22 37,703
2010-08-01 ATSI Ats Medical Inc Option Ex 10,000 .00 0
2010-07-30 ATSI Ats Medical Inc Option Ex 10,000 .00 0
2010-03-15 ATSI Ats Medical Inc Option Ex 35,948 .00 0
2010-03-16 ATSI Ats Medical Inc Sale 13,518 2.50 33,822
2010-02-16 ATSI Ats Medical Inc Sale 1,581 2.39 3,778
2010-02-13 ATSI Ats Medical Inc Option Ex 4,000 .00 0
2009-10-02 ATSI Ats Medical Inc Option Ex 4,000 .00 0
2009-10-02 ATSI Ats Medical Inc Sale 1,500 2.61 3,918
2009-08-01 ATSI Ats Medical Inc Option Ex 10,000 .00 0
2009-07-30 ATSI Ats Medical Inc Option Ex 10,000 .00 0
2009-07-31 ATSI Ats Medical Inc Sale 3,754 3.48 13,063
2009-08-03 ATSI Ats Medical Inc Sale 3,800 3.45 13,110
2009-03-15 ATSI Ats Medical Inc Option Ex 22,736 .00 0
2009-03-16 ATSI Ats Medical Inc Sale 8,800 2.16 19,016
2009-02-13 ATSI Ats Medical Inc Option Ex 4,000 .00 0
2008-10-02 ATSI Ats Medical Inc Option Ex 4,000 .00 0
2008-08-01 ATSI Ats Medical Inc Option Ex 10,000 .00 0
2008-03-14 ATSI Ats Medical Inc Option Ex 5,210 .00 0
2008-02-13 ATSI Ats Medical Inc Option Ex 4,000 .00 0
2007-10-02 ATSI Ats Medical Inc Option Ex 4,000 .00 0
2007-10-02 ATSI Ats Medical Inc Option Ex 4,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kramer Michael R (Chief Financial Officer of Trivascular Technologies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.